AestheticSource Honour NEOSTRATA® Co-founder Dr Eugene J. Van Scott

Honouring Dr Eugene J. Van Scott

May 27, 1922 – July 21, 2025

It is with respect and admiration that we remember the life and legacy of NEOSTRATA® co-founder, Dr Eugene J. Van Scott, who passed away on 21 July 2025 at the age of 103.

Born on May 27, 1922 in Macedon, New York, Dr Van Scott went on to become one of the most influential figures in modern dermatology. Affectionately known as “The Thomas Edison of American Dermatology”, he was best recognised for the discovery of alpha hydroxy acids, alongside longtime collaborator Dr Ruey Yu. The duo later founded skincare company NEOSTRATA®, a leader in dermocosmetics that today continues to advance the field of skin renewal, with 100+ publications and patents supporting its science.

Dr Van Scott’s career was defined by his innovative work and service. He served as founder and the first chief of the Dermatology branch of the National Cancer Institute, and later as Deputy Chairman of the Department of Dermatology at Temple University School of Medicine.

His development of the first effective treatment for cutaneous T-cell lymphoma earned him the highly prestigious Albert Lasker Clinical Medical Research Award in 1972, underscoring his extraordinary contribution to medical science.

Beyond his accolades and achievements, Dr Van Scott will be remembered for his profound impact on patients and their families, both through his research and in medical practice. His kindness, meticulous care, and superb bedside manner earned him the trust and appreciation of his community.

Dr Eugene J. Van Scott’s legacy lives on through the countless lives he touched, the innovations he pioneered, and the field of dermatology he helped to shape.